Kuldeep K Roy

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Venues

Journal of biomolecular structure & dynamics

Current drug targets

Chemical biology & drug design

Molecular diversity

National Institute of Pharmaceutical Education and Research Kolkata

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Institute of Pharmaceutical Education and Research Kolkata Apr 11 2016

India

Assistant Professor :: Pharmacoinformatics

University of Mississippi - Apr 08 2016

United States

Postdoctoral Research Associate :: Department of Biomolecular Sciences

Ewha Womans University

South Korea

Post-doctoral Researcher :: Department of Pharmaceutical and Life Sciences

Torrent Research Center

India

Scientist-II :: Medicinal Chemistry Division

Publications

Smriti Bhardwaj, Kuldeep K Roy
ClpP Peptidase as a Plausible Target for the Discovery of Novel Antibiotics. Current drug targets 25 (2) (2024)
Smriti Bhardwaj, Kuldeep K Roy
ClpP Peptidase as a Plausible Target for the Discovery of Novel Antibiotics. Current drug targets 25 (2) (2024)
Smriti Bhardwaj, Kuldeep K Roy
ClpP Peptidase as a Plausible Target for the Discovery of Novel Antibiotics. Current drug targets 25 (2) (2024)
Smriti Bhardwaj, Kuldeep K Roy
ClpP Peptidase as a Plausible Target for the Discovery of Novel Antibiotics. Current drug targets (2023)
Kuldeep K Roy, Deeti Jyothi, Udita Paul, Soumi Sukla
Identification and validation of novel non-nucleoside class of molecules inhibiting the dengue virus replication. Journal of biomolecular structure & dynamics (2023)
Nandan Sarkar, Pukar Khanal, Ravi Rawat, Yadu Nandan Dey, Kuldeep K Roy
Rosmarinic acid and its derivative's duel as antitubercular agents: insights from computational prediction to functional response in vitro . Journal of biomolecular structure & dynamics (2023)
Bedabrata Ray, Kuldeep K Roy
Deciphering insights into the binding mechanism and plasticity of Telacebec with M. tuberculosis cytochrome bcc-aa3 supercomplex through an unbiased molecular dynamics simulation, free-energy analysis, and DFT study. Journal of biomolecular structure & dynamics (2023)
Ashis Roy, Tonmoy Sarkar, Sebak Datta, Arup Maiti, Monali Chakrabarti, Trisha Mondal, Chaitali Mondal, Apurba Banerjee, Subhasis Roy, Soumen Mukherjee, Pragati Muley, Sabyasachi Chakraborty, Manish Banerjee, Mrinalkanti Kundu, Kuldeep K Roy
Structure-based discovery of (S)-2-amino-6-(4-fluorobenzyl)-5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione as low nanomolar, orally bioavailable autotaxin inhibitor. Chemical biology & drug design 99 (3) (2022)
Mrinalkanti Kundu, Aditi Dutta, Kuldeep K Roy, Sajal K Mal, Shouvik Karmakar, Aritra Mandal, Susanta K Mondal, Sanjay Kumar, Soumya Saha, Subhankar Pradhan, Ratul Sarkar, Monali Chakrabarti, Pradip K Malik, Manish Banerjee
Identification of 5-(3-(methylsulfonyl)phenyl)-3-(4-(methylsulfonyl)phenyl)-3H-imidazo[4,5-b]pyridine as novel orally bioavailable and metabolically stable antimalarial compound for further exploration. Chemical biology & drug design (2022)
Mushtaq Ahmad Wani, Kuldeep K Roy
Development and validation of consensus machine learning-based models for the prediction of novel small molecules as potential anti-tubercular agents. Molecular diversity (2021)
null Bharathi, Kuldeep K Roy
Structural basis for the binding of a selective inverse agonist AF64394 with the human G-protein coupled receptor 3 (GPR3). Journal of biomolecular structure & dynamics (2021)
Mushtaq Ahmad Wani, Prabha Garg, Kuldeep K Roy
Machine learning-enabled predictive modeling to precisely identify the antimicrobial peptides. Medical & biological engineering & computing 59 (11-12) (2021)
Kodidasu Satish Kumar, Ravichandiran Velayutham, Kuldeep K Roy
A systematic computational analysis of human matrix metalloproteinase 13 (MMP-13) crystal structures and structure-based identification of prospective drug candidates as MMP-13 inhibitors repurposable for osteoarthritis. Journal of biomolecular structure & dynamics 38 (10) (2019)
Pankaj Pandey, Kuldeep K Roy, Robert J Doerksen
Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist. Journal of biomolecular structure & dynamics 38 (1) (2019)
Kuldeep K Roy, Mushtaq Ahmad Wani
Emerging opportunities of exploiting mycobacterial electron transport chain pathway for drug-resistant tuberculosis drug discovery. Expert opinion on drug discovery 15 (2) (2019)
Pankaj Pandey, Kuldeep K Roy, Haining Liu, Guoyi Ma, Sara Pettaway, Rama S Gadepalli, John M Rimoldi, Christopher R McCurdy, Stephen J Cutler, Robert J Doerksen
Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists. Molecules (Basel, Switzerland) 23 (10) (2018)
Padmaja Wakchaure, Ravichandiran Velayutham, Kuldeep K Roy
Structure investigation, enrichment analysis and structure-based repurposing of FDA-approved drugs as inhibitors of BET-BRD4. Journal of biomolecular structure & dynamics 37 (12) (2018)

Kuldeep K Roy.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kuldeep K Roy